Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update
Authors
Keywords
Transient abnormal myelopoiesis, Down syndrome, Acute leukaemia, Myeloproliferative disorders
Journal
Current Hematologic Malignancy Reports
Volume 11, Issue 5, Pages 333-341
Publisher
Springer Nature
Online
2016-08-10
DOI
10.1007/s11899-016-0338-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systematic Cellular Disease Models Reveal Synergistic Interaction of Trisomy 21 and GATA1 Mutations in Hematopoietic Abnormalities
- (2016) Kimihiko Banno et al. Cell Reports
- Prenatal therapy in transient abnormal myelopoiesis: a systematic review
- (2015) J A Tamblyn et al. Archives of Disease in Childhood-Fetal and Neonatal Edition
- Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network
- (2015) Aurélie Caye et al. NATURE GENETICS
- Preserved High Probability of Overall Survival with Significant Reduction of Chemotherapy for Myeloid Leukemia in Down Syndrome: A Nationwide Prospective Study in Japan
- (2015) Takashi Taga et al. PEDIATRIC BLOOD & CANCER
- Stem and progenitor cell dysfunction in human trisomies
- (2014) B. Liu et al. EMBO REPORTS
- Outcome of Transplantation for Acute Myelogenous Leukemia in Children with Down Syndrome
- (2013) Johann K. Hitzler et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Naturally occurring oncogenic GATA1 mutants with internal deletions in transient abnormal myelopoiesis in Down syndrome
- (2013) T. Toki et al. BLOOD
- Perturbation of fetal hematopoiesis in a mouse model of Down syndrome's transient myeloproliferative disorder
- (2013) Y. Birger et al. BLOOD
- Exome sequencing identifies putative drivers of progression of transient myeloproliferative disorder to AMKL in infants with Down syndrome
- (2013) S. I. Nikolaev et al. BLOOD
- GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia
- (2013) I. Roberts et al. BLOOD
- Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome
- (2013) Heidrun Boztug et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Liver disease is frequently observed in Down syndrome patients with transient abnormal myelopoiesis
- (2013) Myoung Ja Park et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- The landscape of somatic mutations in Down syndrome–related myeloid disorders
- (2013) Kenichi Yoshida et al. NATURE GENETICS
- Reduced intensity conditioning in allogeneic stem cell transplantation for AML with Down syndrome
- (2013) Hideki Muramatsu et al. PEDIATRIC BLOOD & CANCER
- Clinical characteristics and outcome of refractory/relapsed myeloid leukemia in children with Down syndrome
- (2012) T. Taga et al. BLOOD
- Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971
- (2012) April D. Sorrell et al. CANCER
- Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome
- (2012) Sébastien Malinge et al. JOURNAL OF CLINICAL INVESTIGATION
- Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21
- (2012) A. Roy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells
- (2012) S. T. Chou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells
- (2012) G. A. MacLean et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia
- (2011) K. A. Alford et al. BLOOD
- Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971
- (2011) A. S. Gamis et al. BLOOD
- Perturbed hematopoiesis in the Tc1 mouse model of Down syndrome
- (2010) K. A. Alford et al. BLOOD
- Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis
- (2010) J.-H. Klusmann et al. GENES & DEVELOPMENT
- Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome
- (2009) S. Malinge et al. BLOOD
- ERG Is a Megakaryocytic Oncogene
- (2009) S. Salek-Ardakani et al. CANCER RESEARCH
- Hematopoietic defects in the Ts1Cje mouse model of Down syndrome
- (2008) C. L. Carmichael et al. BLOOD
- Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations
- (2008) O. Tunstall-Pedoe et al. BLOOD
- Treatment and prognostic impact of transient leukemia in neonates with Down syndrome
- (2008) J.-H. Klusmann et al. BLOOD
- Risk factors for early death in neonates with Down syndrome and transient leukaemia
- (2008) Hideki Muramatsu et al. BRITISH JOURNAL OF HAEMATOLOGY
- Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome
- (2007) G. Kirsammer et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More